ArticleJournal of clinical medicine2025

Twelve-Month Outcomes of Anti-VEGF Therapy for nAMD with Brolucizumab, Aflibercept, and Ranibizumab in the Polish National Registry: A Multicenter Database Study.

Sławomir Teper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.